Share Name Share Symbol Market Type Share ISIN Share Description
GlaxoSmithKline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +1.50p +0.10% 1,562.00p 1,562.00p 1,562.50p 1,567.00p 1,558.00p 1,561.50p 1,808,114.00 10:39:32
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 23,923.0 10,526.0 174.3 9.0 76,144.26

GlaxoSmithKline Share Discussion Threads

Showing 13676 to 13699 of 13700 messages
Chat Pages: 548  547  546  545  544  543  542  541  540  539  538  537  Older
DateSubjectAuthorDiscuss
19/1/2017
09:53
19th jan Deutsche hold tp 1800p 19th jan Liberum buy tp 1900p
philanderer
19/1/2017
09:22
IN at 1562.25 (with dividend cash) ..... ;0)
tradermichael
17/1/2017
14:25
Post May speech.. "The pound's on course for its biggest one-day rise against the dollar since 2008"
philanderer
16/1/2017
18:42
'Why Trump Faces Stiff Fight to Slash Drug Prices' HTTPS://www.bloomberg.com/news/articles/2017-01-13/why-trump-faces-stiff-fight-to-slash-drug-prices-quicktake-q-a?cmpid=socialflow-twitter-business&utm_content=business&utm_campaign=socialflow-organic&utm_source=twitter&utm_medium=social
philanderer
16/1/2017
10:28
16th jan Jefferies buy tp 1750p up from 1700p
philanderer
16/1/2017
09:30
Well with the £ @ 12000 against the US$ this is becoming a mouthwatering takeover target imho Trump rally will fade and more cash will pour into these multi national, strong management,blue chip plays with a decent divi.
ny boy
15/1/2017
15:53
Dr B, I think you will find Farage has more than considerable minority support. The forthcoming by election results should be quite interesting even if Farage is no longer leader. In the meantime I continue to hold as the dividend income is remarkable. I'm sure GSK will weather the Trump storm.
chessman2
15/1/2017
09:24
Trump will shake everything up ! However to every action there is an equal and opposite reaction. The real question is how other nations to react to the changes Trump will bring. Particular China on trade and Europe on funding. NATO.
atlantic57
15/1/2017
09:10
Hard to argue against some sort of action against high drug prices. Unfortunately big pharma hasn't covered itself in glory with multiple fines for misconduct. But somehow the price of development also needs to drop to keep the incentive for new drugs.
dr biotech
15/1/2017
07:59
http://www.telegraph.co.uk/business/2017/01/14/clampdown-may-force-pharma-giants-new-bidding-system/
zho
14/1/2017
17:09
http://www.hl.co.uk/news/2017/1/13/4-signs-glaxos-turnaround-is-taking-hold
minerve
12/1/2017
19:36
Trump likely to target drug prices (FT).
alphorn
12/1/2017
19:13
Nope. Don't think so
deanowls
12/1/2017
12:31
Will there is a special dividend this year ??
robrah
12/1/2017
12:26
GSK is viewed as a strategic asset, HMG would be unlikely to allow a sale in its current form imv.
essentialinvestor
12/1/2017
00:52
In the NYSE the share price had recovered most of the drop we saw here by the market close.
woodhawk
12/1/2017
00:17
Trump is a fool, what press conference, a complete shambles, one has to be worried but if these get cheaper I will add more, a takeover from overseas will be even more likely, whilst £ is in a rocky place.
ny boy
11/1/2017
20:55
DT is rattling the cages of various industries, auto, pharma etc. He could, of course turn his attention to all the Delaware company shelters - but then he may have some there too!
alphorn
11/1/2017
20:51
It is difficult to ascertain what affect Trump will have on pharmaceutical companies but I am convinced it is going to be nothing matching his rhetoric. Even with a republican majority there will be strong support for pharmaceutical companies within the party and legislation moving forward will need agreement with the democrats because significantly more(%) than a majority vote is needed to pass some legislation through. Obamacare introduces millions into the healthcare services umbrella and democrats will want to see this remains the case. Additionally, use of hospital beds is extremely expensive and if they want to reduce - probably one of the greatest single costs to hospitals - then choosing the best drug for efficacy most likely saves the most; this leads to not much choice of suppliers where bidding then becomes pointless or impossible. If you want the drug - the sad fact is - you are going to have to pay for it. If you want more choice you need to encourage investment which, in turn, is only attracted if pharma can make money. The buffoon hasn't really thought this one out just like arresting Hillary or building the Mexican fence.
minerve
11/1/2017
20:49
Moving manufacture is a bit of a nonsense; much of the high value (margin) actives will be produced in low tax areas. Pharma manufacture takes a long time to set up with all the approvals - not like producing a pair of socks. DT will have to hit pricing or taxes to achieve anything in the short term.
alphorn
11/1/2017
20:49
By no means a sector meltdown atm, PFE and NVS down under 2%. Would expect some continued volatility.
essentialinvestor
11/1/2017
20:27
Back up to 1602p stateside now.
philanderer
11/1/2017
18:59
Pretty rich bozo.
philo124
11/1/2017
18:46
Despite the rash of doom-mongering here, doesn't look like Trump's rhetoric is having much effect thus far. Can't see the moron lasting too long anyway - probably be lynched by his own supporters when they realise they've elected bozo the clown.
woodhawk
Chat Pages: 548  547  546  545  544  543  542  541  540  539  538  537  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20170119 10:54:46